Therapeutic areas: Oncology, Vaccines
Post-COVID restructuring and the $43B Seagen acquisition have fundamentally reshaped Pfizer\
Key products: Padcev, Adcetris, Eliquis, Xeljanz, Prevnar
Pfizer reps use this room to compare post-restructuring field reality, Seagen-era oncology integration, interview expectations, quota pressure, and culture.
Pfizer reps use this room to compare post-restructuring field reality, Seagen-era oncology integration, interview expectations, quota pressure, and culture.